Clinical study for GI panel, 9/13

Create PDF

BioFire Diagnostics has begun clinical and analytical studies at several hospital-based laboratories in the U.S. to evaluate the company’s FilmArray gastrointestinal panel. BioFire plans to seek CE IVD marking and FDA clearance for the test.

The 23-target GI panel tests for common bacteria, viruses, and protozoa that cause infectious diarrhea. The test is performed in about an hour directly from stool in transport media.

BioFire Diagnostics, 801-736-6354